BUFFALO, N.Y. (AP) - A western New York company says it has signed a $4.6 million contract with Russia to develop anti-infection drugs.
Buffalo-based Cleveland BioLabs Inc. says the contract with the Ministry of Industry and Trade of the Russian Federation was issued under the federation's "Pharma 2020" pharmaceutical development initiative.
The contract announced Tuesday focuses on Xenomycins, a family of compounds being developed as potential treatments for infectious diseases. It's being handled through Panacela Labs, a biotechnology startup company that was founded last year as a joint venture between Cleveland BioLabs and a Russian investment company.
Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Local experts are discussing the impact of the life of South Africa's first black president.
Local school district leaders are watching the wintry weather closely.
The Mercer County Sheriff's Office is warning residents of what it calls a phishing scam.
Global civil rights icon Nelson Mandela, whose legacy is ending South African apartheid, has died.
A busy intersection re-opened late Thursday evening after a crash.